Medicare Enrolled

Dr. Genaro Gutierrez, M.D.

Pain Medicine · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
4316 JAMES CASEY ST, Austin, TX 78745
8558767246
In practice since 2009 (16 years)
NPI: 1396971826 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gutierrez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gutierrez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gutierrez

Dr. Genaro Gutierrez is a pain medicine in Austin, TX, with 16 years in practice. Based on federal Medicare data, Dr. Gutierrez performed 975 Medicare services across 730 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gutierrez received a total of $124,080 from 51 pharmaceutical and/or device companies across 985 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gutierrez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ 975 Medicare services$ $124,080 industry payments

Medicare Practice Summary

Medicare Utilization ↗
975
Medicare services
Bottom 39% in TX for pain medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
730
Unique beneficiaries
$127
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)210$93$657
Insertion of peripheral nerve neurostimulator electrode through skin95$193$24,398
New patient office visit (45-59 min)87$122$850
Insertion of spinal neurostimulator electrode array through skin51$243$25,651
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint39$205$4,778
Injection of lower or sacral spine facet joint using imaging guidance, single level38$190$1,857
Injection of lower or sacral spine facet joint using imaging guidance, second level38$97$951
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint38$61$2,672
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level34$220$2,654
Office visit, established patient (20-29 min)34$61$465
Injection, methylprednisolone acetate, 80 mg33$9$118
Injection, methylprednisolone acetate, 40 mg32$6$57
Injection of substance into middle or upper spine canal using imaging guidance31$76$2,827
Drug screening test24$61$311
Ultrasonic guidance for needle placement22$27$608
Injection of upper or middle spine facet joint using imaging guidance, single level21$112$2,016
Injection of upper or middle spine facet joint using imaging guidance, second level21$63$1,008
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level18$91$1,197
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint18$64$2,828
Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin17$700$9,628
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint17$190$4,732
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance16$154$1,726
Fluoroscopic guidance for needle placement15$25$1,259
Joint injection, major joint13$53$666
Insertion of spinal neurostimulator generator or receiver13$152$3,623
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$124,080
Total received (2018-2024)
Avg $17,726/year across 7 years
Top 0% in TX for pain medicine
51
Companies
985
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$76,530 (61.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,464 (22.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,086 (16.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,851
2023
$31,647
2022
$35,614
2021
$10,715
2020
$11,689
2019
$13,835
2018
$7,731

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SPR Therapeutics, Inc
$60,466
Boston Scientific Corporation
$24,576
Abbott Laboratories
$9,546
SI-BONE, Inc.
$5,505
Nalu Medical, Inc.
$4,786
BOSTON SCIENTIFIC CORPORATION
$3,981
SI-BONE, INC.
$2,290
BIOTRONIK NRO, Inc.
$2,280
Nuvectra Corporation
$1,959
Medtronic, Inc.
$1,833
Relievant Medsystems, Inc.
$1,424
Nevro Corp.
$1,076
Vertiflex, Inc.
$551
Bioventus LLC
$385
Spinal Simplicity, LLC
$347
ABBVIE INC.
$345
Collegium Pharmaceutical, Inc.
$302
PFIZER INC.
$282
Medtronic USA, Inc.
$269
RedHill Biopharma Inc.
$239
PAINTEQ LLC
$214
GRT US Holding, Inc.
$164
Allergan, Inc.
$100
Novartis Pharmaceuticals Corporation
$97
Amgen Inc.
$97
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$94
Forte Bio-Pharma LLC
$92
BioDelivery Sciences International, Inc.
$75
AbbVie Inc.
$74
Biohaven Pharmaceuticals, Inc.
$62
Horizon Therapeutics plc
$56
ARBOR PHARMACEUTICALS, INC.
$56
Scilex Pharmaceuticals Inc.
$40
Pernix Therapeutics Holdings, Inc.
$39
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$38
Vertos Medical, Inc.
$37
IBSA Pharma Inc.
$34
Teva Pharmaceuticals USA, Inc.
$33
Foundation Fusion Solutions, LLC
$32
Shionogi Inc
$25
Averitas Pharma Inc.
$24
Saluda Medical Americas, Inc.
$23
Purdue Pharma L.P.
$20
Daiichi Sankyo Inc.
$18
Orexo US, Inc.
$17
Vertical Pharmaceuticals, LLC
$16
Stratus Medical, LLC
$15
Lilly USA, LLC
$14
Flexion Therapeutics, Inc.
$12
INSYS Therapeutics Inc
$11
AKRIMAX PHARMACEUTICALS, LLC
$10
Top 3 companies account for 76.2% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · Algovita · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BIOTRONIK · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD DNA CAPTURE REAGENTS · DRG Accessories · DRG IPGs · DRG leads · DUEXIS · Durolane · ELYXYB - celecoxib · EMGALITY · ETERNA · Evoke · Fixate · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · General - Therapies · HA MINUTEMAN G3-R · Horizant · IFUSE IMPLANT · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Intracept · LORZONE · LYRICA · Licart · Morphabond ER · Movantik · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Nimbus · OCTRODE · OXYCONTIN · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PROCLAIM · PROLATE · Primlev · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prospera · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SUBSYS · SYNCHROMEDII · Senza · Senza II · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Stimrouter Implantable Kit · Superion ISS · Symproic · UBRELVY · VANTA ADAPTIVESTIM · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zubsolv · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for pain medicine in TX.

Equivalent to $12,726 per 100 Medicare services performed
Looking for a pain medicine in Austin?
Compare pain medicines in the Austin area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain Medicines within 10 mi
1
Per 100K population
0.1
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gutierrez is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 0%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gutierrez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gutierrez performed 210 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gutierrez receive payments from pharmaceutical companies?
Yes. Dr. Gutierrez received a total of $124,080 from 51 companies across 985 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gutierrez's costs compare to other pain medicines in Austin?
Dr. Gutierrez's average Medicare payment per service is $127. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gutierrez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →